AbbVie Inc. (ABBV) vs Meta Platforms, Inc. (META)
A side-by-side comparison of AbbVie Inc. and Meta Platforms, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ABBV is classified in Healthcare; META is classified in Communication Services. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ABBV
AbbVie Inc.
$263.48HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
META
Meta Platforms, Inc.
$593.41Communication ServicesDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — ABBV vs META
growth of $100 · dividends reinvested · last 14yABBV +1164.7%META +2056.4%META compounded faster
ABBV META
ABBV vs META: by the numbers
- •META is the larger company ($1.51T vs $465.51B market cap).
- •META trades at the lower trailing earnings multiple (21.60 vs 125.98 P/E), one valuation lens rather than an overall verdict.
- •META converts more revenue to profit (32.84% vs 5.79% net margin).
- •META grew revenue faster over the past five years (17.89% vs 4.59% CAGR).
- •ABBV pays the higher dividend yield (2.62% vs 0.35%).
Metrics side by side
Valuation
| Metric | ABBV | META |
|---|---|---|
| P/E ratio | 125.98 | 21.60 |
| Forward P/E | N/A | 18.03 |
| P/S ratio | 7.26 | 7.08 |
| P/B ratio | 16.57 | 6.25 |
| PEG ratio | N/A | 1.16 |
| EV / EBITDA | 20.46 | 14.51 |
| FCF yield | 4.58% | 3.17% |
Profitability
| Metric | ABBV | META |
|---|---|---|
| Gross margin | 70.68% | 81.94% |
| Operating margin | 27.60% | 41.21% |
| Net margin | 5.79% | 32.84% |
| ROE | 13.23% | 28.97% |
| ROIC | 12.97% | 17.95% |
Dividends
| Metric | ABBV | META |
|---|---|---|
| Dividend yield | 2.62% | 0.35% |
| Payout ratio | 284.39% | 8.76% |
Growth (annualized)
| Metric | ABBV | META |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 17.89% |
| EPS CAGR (5Y) | -2.79% | 18.60% |
| FCF CAGR (5Y) | 3.24% | 14.84% |
| Total return CAGR (5Y) | 21.24% | 10.03% |
Frequently asked
- Which has the lower trailing P/E, ABBV or META?
- META has the lower trailing P/E: ABBV trades at 125.98 and META at 21.60. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or META?
- Over the past five years, META grew revenue faster — ABBV at a 4.59% CAGR versus META at 17.89%.
- Does ABBV or META pay a bigger dividend?
- ABBV yields 2.62% and META yields 0.35% based on trailing dividends and the latest price.
- Is ABBV or META more profitable?
- META runs the higher net margin — ABBV at 5.79% versus META at 32.84%.
- How have ABBV and META total returns compared?
- Over the past 10 years, ABBV delivered 19.57% and META delivered 17.02% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioMeta Platforms P/E ratioAbbVie dividend yieldMeta Platforms dividend yieldAbbVie ROEMeta Platforms ROEAbbVie operating marginMeta Platforms operating marginAbbVie revenue growthMeta Platforms revenue growthAbbVie free cash flowMeta Platforms free cash flow
AbbVie & Meta Platforms appear in these rankings
Highest Dividend Yield Stocks25+ Year Dividend GrowersFastest Revenue Growth StocksHighest ROE Stocks
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.